Co-Diagnostics, Inc.

CODX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$38-$35-$14$37
Dep. & Amort.$1$1$1$0
Deferred Tax$0-$2-$5$1
Stock-Based Comp.$5$8$8$6
Change in WC$3$6$6-$3
Other Non-Cash-$1$0$11$1
Operating Cash Flow-$29-$22$7$41
Investing Activities
PP&E Inv.-$1-$1-$1-$1
Net Acquisitions-$0$0$0$2
Inv. Purchases-$41-$110-$68$0
Inv. Sales/Matur.$59$127$11$3
Other Inv. Act.$0$0$0$0
Investing Cash Flow$17$15-$58$4
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0-$1-$14$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0-$1-$14$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$12-$8-$66$46
Supplemental Information
Beg. Cash$15$23$89$43
End Cash$3$15$23$89
Free Cash Flow-$30-$23$5$40
Co-Diagnostics, Inc. (CODX) Financial Statements & Key Stats | AlphaPilot